Pfizer's Monthly GLP-1 Obesity Injection Shows Competitive Promise
Pfizer's PF-08653944 shows promising monthly dosing with notable weight loss in the VESPER-3 trial and a competitive edge over weekly injections.
Latest right now for #pfizer
Pfizer Beats Q4 2025 Estimates as Non-COVID Growth Fuels Momentum
Pfizer beats Q4 2025 estimates on non-COVID growth and outlines a steady 2026 outlook across vaccines, oncology, and more.
TrumpRx Launches to Lower Drug Prices with Pfizer Deal
President Trump unveils TrumpRx to lower prescription drug costs through a direct-to-consumer platform and a Pfizer deal.
Pfizer's MFN Pricing Deal Reshapes U.S. Drug Costs
Pfizer's MFN pricing deal aims to lower drug costs and boost access, setting a new industry precedent.
Pfizer Wins $10B Metsera Acquisition Expands Obesity Treatment Pipeline
Pfizer secures a $10B deal to acquire Metsera, boosting obesity therapies and signaling strategic growth in biotech.
Trump Secures Historic MFN Drug-Price Deal with AstraZeneca
Trump announces a landmark MFN drug-price pact with AstraZeneca to reduce U.S. costs and align prices with wealthier nations.
